Oxidative Stress Vulnerable Neurons

Oxidative Stress Vulnerable Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Oxidative Stress Vulnerable Neurons</th>
</tr>
<tr>
<td class="label">Factor</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">High Fe2+</td>
<td>Fenton reaction → [ROS](/entities/reactive-oxygen-species)</td>
</tr>
<tr>
<td class="label">Neuromelanin</td>
<td>Pro-oxidant in SNc</td>
</tr>
<tr>
<td class="label">Dopamine oxidation</td>
<td>Reactive quinones</td>
</tr>
<tr>
<td class="label">High Ca2+ influx</td>
<td>Mitochondrial ROS</td>
</tr>
<tr>
<td class="label">System</td>
<td>Component</td>
</tr>
<tr>
<td class="label">Enzymatic</td>
<td>SOD, catalase, GPx</td>
</tr>
<tr>
<td class="label">Non-enzymatic</td>
<td>GSH, vitamin E, C</td>
</tr>
<tr>
<td class="label">Metal binding</td>
<td>Ferritin, transferrin</td>
</tr>
<tr>
<td class="label">DNA repair</td>
<td>OGG1, XPA</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Example</td>
</tr>
<tr>
<td class="label">Direct antioxidants</td>
<td>[Vitamin E](/therapeutics/vitamin-e-neuroprotection), [CoQ10](/therapeutics/coenzyme-q10-parkinsons)</td>
</tr>
<tr>
<td class="label">SOD mimetics</td>
<td>[MitoQ](/therapeutics/mitoq-neurodegeneration)</td>
</tr>
<tr>
<td class="label">Metal chelation</td>
<td>[Deferoxamine](/therapeutics/metal-chelation-therapy)</td>
</tr>
<tr>
<td class="label">[Nrf2](/mechanisms/n

Oxidative Stress Vulnerable Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Oxidative Stress Vulnerable Neurons</th>
</tr>
<tr>
<td class="label">Factor</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">High Fe2+</td>
<td>Fenton reaction → [ROS](/entities/reactive-oxygen-species)</td>
</tr>
<tr>
<td class="label">Neuromelanin</td>
<td>Pro-oxidant in SNc</td>
</tr>
<tr>
<td class="label">Dopamine oxidation</td>
<td>Reactive quinones</td>
</tr>
<tr>
<td class="label">High Ca2+ influx</td>
<td>Mitochondrial ROS</td>
</tr>
<tr>
<td class="label">System</td>
<td>Component</td>
</tr>
<tr>
<td class="label">Enzymatic</td>
<td>SOD, catalase, GPx</td>
</tr>
<tr>
<td class="label">Non-enzymatic</td>
<td>GSH, vitamin E, C</td>
</tr>
<tr>
<td class="label">Metal binding</td>
<td>Ferritin, transferrin</td>
</tr>
<tr>
<td class="label">DNA repair</td>
<td>OGG1, XPA</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Example</td>
</tr>
<tr>
<td class="label">Direct antioxidants</td>
<td>[Vitamin E](/therapeutics/vitamin-e-neuroprotection), [CoQ10](/therapeutics/coenzyme-q10-parkinsons)</td>
</tr>
<tr>
<td class="label">SOD mimetics</td>
<td>[MitoQ](/therapeutics/mitoq-neurodegeneration)</td>
</tr>
<tr>
<td class="label">Metal chelation</td>
<td>[Deferoxamine](/therapeutics/metal-chelation-therapy)</td>
</tr>
<tr>
<td class="label">[Nrf2](/mechanisms/nrf2-oxidative-stress) activators</td>
<td>[Sulforaphane](/therapeutics/sulforaphane-neuroprotection)</td>
</tr>
<tr>
<td class="label">Mitochondrial antioxidants</td>
<td>[MitoTEMPO](/therapeutics/mitoempower-neurodegeneration)</td>
</tr>
</table>

Oxidative Stress Vulnerable [Neurons](/entities/neurons) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

This page provides comprehensive information about the cell type. See the content below for detailed information. [@barnham2004]

Certain neuronal populations are particularly vulnerable to oxidative stress due to their high metabolic rate, specific neurotransmitter systems, and limited antioxidant capacity. This vulnerability is a key factor in many neurodegenerative diseases.

Why Neurons Are Vulnerable

High Metabolic Demand

• Constant ATP requirements
• High oxygen consumption
• Active ion pumping
• Neurotransmitter cycling

Specific Vulnerabilities

Vulnerable Neuron Populations

Substantia Nigra Pars Compacta

• High iron accumulation
• Neuromelanin (pro-oxidant)
• Dopamine metabolism
• High mitochondrial demand

Locus Coeruleus

• Noradrenergic transmission
• High metabolic activity
• Early involvement in AD, PD

Motor Neurons

• Large cell bodies
• Long axons
• High calcium influx

Hippocampal CA1

• High metabolic activity
• High glutamate receptor density
• Early target in AD

Oxidative Stress Mechanisms

Sources of ROS

Antioxidant Defenses

Antioxidant Therapy Approaches

Neurodegeneration Context

Alzheimer's Disease {#alzheimers-disease}

• [Oxidative stress](/mechanisms/oxidative-stress) in [hippocampus](/brain-regions/hippocampus)
• CA1 pyramidal neurons highly vulnerable
• [Amyloid-beta](/proteins/amyloid-beta) induces [ROS](/mechanisms/oxidative-stress)
• [Tau](/proteins/tau) pathology increases vulnerability

Parkinson's Disease {#parkinsons-disease}

• [Substantia nigra](/brain-regions/substantia-nigra) neurons most vulnerable
• [Neuromelanin](/proteins/neuromelanin) accumulation generates [ROS](/mechanisms/oxidative-stress)
• [Dopamine](/entities/dopamine) oxidation produces reactive quinones
• [Mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction) amplifies [oxidative stress](/mechanisms/oxidative-stress)

Amyotrophic Lateral Sclerosis {#als}

• [Motor neurons](/cell-types/motor-neurons) vulnerable via high metabolic demand
• [SOD1](/genes/sod1) mutations cause familial ALS
• [Oxidative stress](/mechanisms/oxidative-stress) in spinal cord
• [Protein aggregation](/mechanisms/protein-aggregation) generates [ROS](/mechanisms/oxidative-stress)

Huntington's Disease {#huntingtons}

• [Striatal neurons](/brain-regions/basal-ganglia) (medium spiny) vulnerable
• [Huntingtin](/proteins/huntingtin-protein) mutation increases [ROS](/mechanisms/oxidative-stress)
• [Mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction) in [striatum](/brain-regions/basal-ganglia)

Molecular Mechanisms

Protein Oxidation

• Carbonylation of key enzymes
• [Proteasome](/mechanisms/ubiquitin-proteasome-system) dysfunction
• [Autophagy](/mechanisms/autophagy) impairment

Lipid Peroxidation

• [Membrane damage](/mechanisms/oxidative-stress) in neurons
• [Ferroptosis](/mechanisms/ferroptosis) pathway activation
• [Docosahexaenoic acid](/mechanisms/oxidative-stress) (DHA) vulnerability

DNA Damage

• 8-OHdG accumulation in neurons
• [Base excision repair](/mechanisms/dna-damage-repair) impairment
• Mitochondrial DNA deletions

Therapeutic Strategies

Nrf2 Pathway Activation

• [Sulforaphane](/therapeutics/sulforaphane-neuroprotection) upregulates antioxidant response
• [Dimethyl fumarate](/therapeutics/dimethyl-fumarate-neurodegeneration) activates Nrf2
• [Curcumin](/therapeutics/curcumin-neurodegeneration) modulates Nrf2 pathway

Mitochondrial-Targeted Antioxidants

• [MitoQ](/therapeutics/mitoq-neurodegeneration) (CoQ10 conjugated to TPP)
• [MitoTEMPO](/therapeutics/mitoempower-neurodegeneration) (SOD mimetic)
• [SkQ1](/therapeutics/skq1-vismura-neurodegeneration) (plastoquinone derivative)

Metal Chelation

• [Deferoxamine](/therapeutics/metal-chelation-therapy) for iron overload
• [Clioquinol](/therapeutics/clioquinol-neurodegeneration) for copper-zinc
• [PBT2](/therapeutics/pbt2-neurodegeneration) as blood-brain barrier chelator

See Also

• [Oxidative Stress](/mechanisms/oxidative-stress)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Huntington's Disease](/diseases/huntingtons)
• [Substantia Nigra](/brain-regions/substantia-nigra)
• [Neuroprotection](/therapeutics/neuroprotection)
• [Ferroptosis](/mechanisms/ferroptosis)
• [Neuroinflammation](/mechanisms/neuroinflammation)

Pathway Diagram

The following diagram shows the key molecular relationships involving Oxidative Stress Vulnerable Neurons discovered through SciDEX knowledge graph analysis: